Related Articles
Lapatinib inhibits the growth of esophageal squamous cell carcinoma and synergistically interacts with 5-fluorouracil in patient-derived xenograft models
Combined molecular targeted drug therapy for EGFR and HER-2 in head and neck squamous cell carcinoma cell lines
Antitumor effect of gefitinib on head and neck squamous cell carcinoma enhanced by trastuzumab
Co-treatment of wild‑type EGFR head and neck cancer cell lines with afatinib and cisplatin
Antitumor effects of ZD6474 on head and neck squamous cell carcinoma